Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.0…

Overview of attention for article published in Lancet Oncology, December 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
twitter: 51 X users

facebook: 1 Facebook page
guideline: 4 clinical guideline sources

Readers on

mendeley: 217 Mendeley

So far, Altmetric has seen 57 X posts from 51 X users, with an upper bound of 165,678 followers.

Short-term Androgen Suppression and Radiotherapy Versus Intermediate-Term Androgen Suppression and Radiotherapy, With or Without Zoledronic Acid, in Men With Locally Advanced Prostate Cancer (TROG 03.04 RADAR): 10-year Results From a Randomised, Phase 3…

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results… https://t.co/KJXeImA1Wb H/T…

@ChapinMD https://t.co/A9ygWJQP6g

RT @TheLancetOncol: In our Feb issue: 10-year results from the TROG 03.04 RADAR trial on short-term vs intermediate-term #androgen suppress…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 53 additional X posts.